Articles citing EurekAlert

Study Reveals CBN's Potential in Neuroprotection

2 Sources

Salk Institute researchers have discovered that CBN, a lesser-known cannabinoid with neuroprotective properties, could lead to future therapies for neurodegenerative diseases and brain injury prevention. The search for effective treatments for neurodegenerative diseases has long been a challenge, particularly as the global population ages and the prevalence of conditions like Alzheimer’s and Parkinson’s continues to rise. However, recent research from the Salk Institute offers a glimmer of hope, focusing on a lesser-known cannabinoid, cannabinol (CBN), and its potential to protect the brain against aging and neurodegeneration.

Read article

Sources from EurekAlert

From left: Pamela Maher and Zhibin Liang.

EurekAlert EurekAlert

Cited in: Study Reveals CBN's Potential in Neuroprotection

Protecting brain cells with cannabinol

3min read

Salk scientist created four Cannabis-derived CBN analogs (chemical look-a-likes) with enhanced neuroprotective properties and potential for therapeutic application in neurological disorders like Alzheimer’s, Parkinson’s, and traumatic brain injury. Their findings reveal novel aspects of CBN's neuroprotective activity and demonstrate the clinical potential of CBN and value of studying its analogs.